{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:00:06Z","timestamp":1771020006006,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020950","name":"Department of Pathology, Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011594","name":"Penn State College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.anndiagpath.2024.152357","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T05:25:20Z","timestamp":1719033920000},"page":"152357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinicopathological risk factors associated with tumor relapse of upper tract urothelial carcinoma after radical nephroureterectomy: A single institution 20-year experience"],"prefix":"10.1016","volume":"73","author":[{"given":"Yong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua I.","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"DeGraff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2024.152357_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0010","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","article-title":"Diagnosis and Management of non-Metastatic Upper Tract Urothelial Carcinoma: AUA\/SUO guideline","volume":"209","author":"Coleman","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0015","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MOU.0000000000000943","article-title":"Molecular intricacies of upper tract urothelial carcinoma and their relevance for therapy considerations","volume":"32","author":"Berndl","year":"2022","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0025","first-page":"11","article-title":"Upper tract urothelial carcinoma: a rare malignancy with distinct Immuno-genomic features in the era of precision-based therapies","author":"Evmorfopoulos","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/OTT.S225301","article-title":"Optimal Management of Upper Tract Urothelial Carcinoma: current perspectives","volume":"13","author":"Leow","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupret","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0040","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","article-title":"Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0045","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1245\/s10434-013-3349-z","article-title":"Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location","volume":"21","author":"Tanaka","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0050","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.21037\/tau.2020.03.47","article-title":"Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract","volume":"9","author":"Lonergan","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0060","first-page":"13","article-title":"Clinical characteristics and current status of treatment for recurrent bladder Cancer after surgeries on upper tract urothelial carcinoma","author":"Hu","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.euros.2023.01.004","article-title":"Bladder recurrence following upper tract surgery for urothelial carcinoma: a contemporary review of risk factors and management strategies","volume":"49","author":"Mertens","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.path.2022.07.003","article-title":"Urothelial carcinoma: divergent differentiation and morphologic subtypes","volume":"15","author":"Gandhi","year":"2022","journal-title":"Surg Pathol Clin"},{"issue":"Suppl. 2","key":"10.1016\/j.anndiagpath.2024.152357_bb0075","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1038\/modpathol.2009.26","article-title":"Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications","volume":"22","author":"Amin","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0080","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1245\/s10434-014-3657-y","article-title":"Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma","volume":"21","author":"Tanaka","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12957-020-01877-w","article-title":"Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma","volume":"18","author":"Li","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13014-022-02020-7","article-title":"Optimal management of recurrent and metastatic upper tract urothelial carcinoma: implications of intensity modulated radiation therapy","volume":"17","author":"Kim","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0095","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.21037\/tau-23-45","article-title":"Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma","volume":"12","author":"Zganjar","year":"2023","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.juro.2012.04.020","article-title":"The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma","volume":"188","author":"Kim","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.urology.2007.03.033","article-title":"Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection","volume":"70","author":"Wasco","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12885-017-3520-1","article-title":"Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival","volume":"17","author":"Li","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0115","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1038\/s41467-022-34251-3","article-title":"FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation","volume":"13","author":"Warrick","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.juro.2007.03.033","article-title":"Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome","volume":"178","author":"Holm\u00e4ng","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0090-4295(85)90526-6","article-title":"Squamous cell carcinoma of renal pelvis","volume":"25","author":"Blacher","year":"1985","journal-title":"Urology"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0130","doi-asserted-by":"crossref","unstructured":"Kim JK, Moon KC, Jeong CW et al. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Urol Oncol 2017; 35: 458 e459\u2013458 e415.","DOI":"10.1016\/j.urolonc.2017.02.010"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.21037\/atm.2019.07.31","article-title":"Impact of squamous differentiation on intravesical recurrence and prognosis of patients with upper tract urothelial carcinoma","volume":"7","author":"Yu","year":"2019","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152357_bb0140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/iju.15376","article-title":"Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy","volume":"31","author":"Yu","year":"2024","journal-title":"Int J Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0145","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bju.14751","article-title":"Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy","volume":"124","author":"Zamboni","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0150","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00345-015-1715-0","article-title":"The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy","volume":"34","author":"Tang","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0155","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.urolonc.2012.04.009","article-title":"Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital","volume":"31","author":"Shah","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0160","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"793\u2013809","key":"10.1016\/j.anndiagpath.2024.152357_bb0165","article-title":"Molecular classification and diagnostics of upper urinary tract urothelial carcinoma","volume":"39","author":"Fujii","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.anndiagpath.2024.152357_bb0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ccell.2021.05.004","article-title":"Molecular subtypes of upper tract urothelial cancer: setting the stage for precision therapy","volume":"39","author":"McConkey","year":"2021","journal-title":"Cancer Cell"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:29:16Z","timestamp":1731652156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424000947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":34,"alternative-id":["S1092913424000947"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152357","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological risk factors associated with tumor relapse of upper tract urothelial carcinoma after radical nephroureterectomy: A single institution 20-year experience","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152357"}}